Cargando…

From COPD epidemiology to studies of pathophysiological disease mechanisms: challenges with regard to study design and recruitment process: Respiratory and Cardiovascular Effects in COPD (KOLIN)

Background: Chronic obstructive pulmonary disease (COPD) is a largely underdiagnosed disease including several phenotypes. In this report, the design of a study intending to evaluate the pathophysiological mechanism in COPD in relation to the specific phenotypes non-rapid and rapid decline in lung f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindberg, Anne, Linder, Robert, Backman, Helena, Eriksson Ström, Jonas, Frølich, Andreas, Nilsson, Ulf, Rönmark, Eva, Johansson Strandkvist, Viktor, Behndig, Annelie F., Blomberg, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738647/
https://www.ncbi.nlm.nih.gov/pubmed/29296255
http://dx.doi.org/10.1080/20018525.2017.1415095
_version_ 1783287737809371136
author Lindberg, Anne
Linder, Robert
Backman, Helena
Eriksson Ström, Jonas
Frølich, Andreas
Nilsson, Ulf
Rönmark, Eva
Johansson Strandkvist, Viktor
Behndig, Annelie F.
Blomberg, Anders
author_facet Lindberg, Anne
Linder, Robert
Backman, Helena
Eriksson Ström, Jonas
Frølich, Andreas
Nilsson, Ulf
Rönmark, Eva
Johansson Strandkvist, Viktor
Behndig, Annelie F.
Blomberg, Anders
author_sort Lindberg, Anne
collection PubMed
description Background: Chronic obstructive pulmonary disease (COPD) is a largely underdiagnosed disease including several phenotypes. In this report, the design of a study intending to evaluate the pathophysiological mechanism in COPD in relation to the specific phenotypes non-rapid and rapid decline in lung function is described together with the recruitment process of the study population derived from a population based study. Method: The OLIN COPD study includes a population-based COPD cohort and referents without COPD identified in 2002–04 (n = 1986), and thereafter followed annually since 2005. Lung function decline was estimated from baseline in 2002–2004 to 2010 (first recruitment phase) or to 2012/2013 (second recruitment phase). Individuals who met the predefined criteria for the following four groups were identified; group A) COPD grade 2–3 with rapid decline in FEV(1) and group B) COPD grade 2–3 without rapid decline in FEV(1) (≥60 and ≤30 ml/year, respectively), group C) ever-smokers, and group D) non-smokers with normal lung function. Groups A–C included ever-smokers with >10 pack years. The intention was to recruit 15 subjects in each of the groups A-D. Results: From the database groups A–D were identified; group A n = 37, group B n = 29, group C n = 41, and group D n = 55. Fifteen subjects were recruited from groups C and D, while this goal was not reached in the groups A (n = 12) and B (n = 10). The most common reasons for excluding individuals identified as A or B were comorbidities contraindicating bronchoscopy, or inflammatory diseases/immune suppressive medication expected to affect the outcome. Conclusion: The study is expected to generate important results regarding pathophysiological mechanisms associated with rate of decline in lung function among subjects with COPD and the in-detail described recruitment process, including reasons for non-participation, is a strength when interpreting the results in forthcoming studies.
format Online
Article
Text
id pubmed-5738647
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-57386472018-01-02 From COPD epidemiology to studies of pathophysiological disease mechanisms: challenges with regard to study design and recruitment process: Respiratory and Cardiovascular Effects in COPD (KOLIN) Lindberg, Anne Linder, Robert Backman, Helena Eriksson Ström, Jonas Frølich, Andreas Nilsson, Ulf Rönmark, Eva Johansson Strandkvist, Viktor Behndig, Annelie F. Blomberg, Anders Eur Clin Respir J Research Article Background: Chronic obstructive pulmonary disease (COPD) is a largely underdiagnosed disease including several phenotypes. In this report, the design of a study intending to evaluate the pathophysiological mechanism in COPD in relation to the specific phenotypes non-rapid and rapid decline in lung function is described together with the recruitment process of the study population derived from a population based study. Method: The OLIN COPD study includes a population-based COPD cohort and referents without COPD identified in 2002–04 (n = 1986), and thereafter followed annually since 2005. Lung function decline was estimated from baseline in 2002–2004 to 2010 (first recruitment phase) or to 2012/2013 (second recruitment phase). Individuals who met the predefined criteria for the following four groups were identified; group A) COPD grade 2–3 with rapid decline in FEV(1) and group B) COPD grade 2–3 without rapid decline in FEV(1) (≥60 and ≤30 ml/year, respectively), group C) ever-smokers, and group D) non-smokers with normal lung function. Groups A–C included ever-smokers with >10 pack years. The intention was to recruit 15 subjects in each of the groups A-D. Results: From the database groups A–D were identified; group A n = 37, group B n = 29, group C n = 41, and group D n = 55. Fifteen subjects were recruited from groups C and D, while this goal was not reached in the groups A (n = 12) and B (n = 10). The most common reasons for excluding individuals identified as A or B were comorbidities contraindicating bronchoscopy, or inflammatory diseases/immune suppressive medication expected to affect the outcome. Conclusion: The study is expected to generate important results regarding pathophysiological mechanisms associated with rate of decline in lung function among subjects with COPD and the in-detail described recruitment process, including reasons for non-participation, is a strength when interpreting the results in forthcoming studies. Taylor & Francis 2017-12-17 /pmc/articles/PMC5738647/ /pubmed/29296255 http://dx.doi.org/10.1080/20018525.2017.1415095 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lindberg, Anne
Linder, Robert
Backman, Helena
Eriksson Ström, Jonas
Frølich, Andreas
Nilsson, Ulf
Rönmark, Eva
Johansson Strandkvist, Viktor
Behndig, Annelie F.
Blomberg, Anders
From COPD epidemiology to studies of pathophysiological disease mechanisms: challenges with regard to study design and recruitment process: Respiratory and Cardiovascular Effects in COPD (KOLIN)
title From COPD epidemiology to studies of pathophysiological disease mechanisms: challenges with regard to study design and recruitment process: Respiratory and Cardiovascular Effects in COPD (KOLIN)
title_full From COPD epidemiology to studies of pathophysiological disease mechanisms: challenges with regard to study design and recruitment process: Respiratory and Cardiovascular Effects in COPD (KOLIN)
title_fullStr From COPD epidemiology to studies of pathophysiological disease mechanisms: challenges with regard to study design and recruitment process: Respiratory and Cardiovascular Effects in COPD (KOLIN)
title_full_unstemmed From COPD epidemiology to studies of pathophysiological disease mechanisms: challenges with regard to study design and recruitment process: Respiratory and Cardiovascular Effects in COPD (KOLIN)
title_short From COPD epidemiology to studies of pathophysiological disease mechanisms: challenges with regard to study design and recruitment process: Respiratory and Cardiovascular Effects in COPD (KOLIN)
title_sort from copd epidemiology to studies of pathophysiological disease mechanisms: challenges with regard to study design and recruitment process: respiratory and cardiovascular effects in copd (kolin)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738647/
https://www.ncbi.nlm.nih.gov/pubmed/29296255
http://dx.doi.org/10.1080/20018525.2017.1415095
work_keys_str_mv AT lindberganne fromcopdepidemiologytostudiesofpathophysiologicaldiseasemechanismschallengeswithregardtostudydesignandrecruitmentprocessrespiratoryandcardiovasculareffectsincopdkolin
AT linderrobert fromcopdepidemiologytostudiesofpathophysiologicaldiseasemechanismschallengeswithregardtostudydesignandrecruitmentprocessrespiratoryandcardiovasculareffectsincopdkolin
AT backmanhelena fromcopdepidemiologytostudiesofpathophysiologicaldiseasemechanismschallengeswithregardtostudydesignandrecruitmentprocessrespiratoryandcardiovasculareffectsincopdkolin
AT erikssonstromjonas fromcopdepidemiologytostudiesofpathophysiologicaldiseasemechanismschallengeswithregardtostudydesignandrecruitmentprocessrespiratoryandcardiovasculareffectsincopdkolin
AT frølichandreas fromcopdepidemiologytostudiesofpathophysiologicaldiseasemechanismschallengeswithregardtostudydesignandrecruitmentprocessrespiratoryandcardiovasculareffectsincopdkolin
AT nilssonulf fromcopdepidemiologytostudiesofpathophysiologicaldiseasemechanismschallengeswithregardtostudydesignandrecruitmentprocessrespiratoryandcardiovasculareffectsincopdkolin
AT ronmarkeva fromcopdepidemiologytostudiesofpathophysiologicaldiseasemechanismschallengeswithregardtostudydesignandrecruitmentprocessrespiratoryandcardiovasculareffectsincopdkolin
AT johanssonstrandkvistviktor fromcopdepidemiologytostudiesofpathophysiologicaldiseasemechanismschallengeswithregardtostudydesignandrecruitmentprocessrespiratoryandcardiovasculareffectsincopdkolin
AT behndigannelief fromcopdepidemiologytostudiesofpathophysiologicaldiseasemechanismschallengeswithregardtostudydesignandrecruitmentprocessrespiratoryandcardiovasculareffectsincopdkolin
AT blomberganders fromcopdepidemiologytostudiesofpathophysiologicaldiseasemechanismschallengeswithregardtostudydesignandrecruitmentprocessrespiratoryandcardiovasculareffectsincopdkolin